L

Leena Gandhi

Celldex Therapeutics (United States)

ORCID: 0000-0002-2398-9179

Publishes on Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies. 345 papers and 36.7k citations.

PubIndex Score98Top 2%How it's scored

345Publications

36.7kTotal Citations

First publication: 1985First senior author: 1985

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies Monoclonal and Polyclonal Antibodies Research Cancer Genomics and Diagnostics

Top publicationsby citations

Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Scott Gettinger, Julie R. Brahmer, Leora Horn et al.|Journal of Clinical Oncology|2015

Cited by 1.2k

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

Eliezer M. Van Allen, Levi A. Garraway, Nikhil Wagle et al.|Nature Medicine|2014

Cited by 571

Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors

Matthew D. Hellmann, Toshihiko Doi, Anna M. Szpurka et al.|Clinical Cancer Research|2021

Cited by 111